March 3 (Reuters) - Cardiome Pharma Corp COM.TO
* Cardiome Pharma Corp - received authorization from French transparency pricing commission to begin selling Xydalba in France
* Cardiome Pharma Corp - it has launched Xydalba in France after receiving authorization Source text for Eikon: ID:nCNWc4NNJa Further company coverage: COM.TO